(Q28256358)

24

0 references

Jan Delabie

6

0 references

Alison H Banham

Alison H Banham

5

0 references

Miguel A. Piris

Miguel A Piris

4

0 references

Elías Campo

Elias Campo

21

0 references

Randy D Gascoyne

17

Randy D Gascoyne

0 references

Wing C Chan

25

Wing C Chan

0 references

Dennis D Weisenburger

2

Dennis D Weisenburger

0 references

Julie M Vose

11

Julie M Vose

0 references

Andreas Rosenwald

18

Andreas Rosenwald

0 references

Elaine Jaffe

22

Elaine S Jaffe

0 references

Lisa M Rimsza

20

Lisa M Rimsza

0 references

Rita M. Braziel

7

Rita M Braziel

0 references

David L Jaye

23

David L Jaye

0 references

Javeed Iqbal

9

Javeed Iqbal

0 references

Timothy Greiner

3

Timothy C Greiner

0 references

Zhongfeng Liu

16

Zhongfeng Liu

0 references

William W L Choi

1

William W L Choi

0 references

Huimin Geng

8

Huimin Geng

0 references

author name string

Georg Lenz

10

0 references

Christine P Hans

12

0 references

Kai Fu

13

0 references

Lynette M Smith

14

0 references

Min Li

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.

15

0 references

language of work or name

English

0 references

publication date

1 September 2009

0 references

published in

Clinical Cancer Research

0 references

volume

15

0 references

issue

17

0 references

page(s)

5494-502

0 references

cites work

1 reference

12 December 2020

Identification of centerin: a novel human germinal center B cell-restricted serpin

1 reference

12 December 2020

Stromal gene signatures in large-B-cell lymphomas

1 reference

12 December 2020

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

1 reference

12 December 2020

MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer

1 reference

12 December 2020

Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

1 reference

12 December 2020

Building an outcome predictor model for diffuse large B-cell lymphoma

1 reference

12 December 2020

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

1 reference

12 December 2020

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

12 December 2020

The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.

1 reference

12 December 2020

Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.

1 reference

12 December 2020

Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors

1 reference

12 December 2020

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

12 December 2020

Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

12 December 2020

Expression of bcl-6 and CD10 in Primary Mediastinal Large B-Cell Lymphoma

1 reference

12 December 2020

Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.

1 reference

12 December 2020

Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation

1 reference

12 December 2020

Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas

1 reference

12 December 2020

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome

1 reference

12 December 2020

Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups.

1 reference

12 December 2020

Molecular pathogenesis of diffuse large B-cell lymphoma

1 reference

12 December 2020

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

1 reference

12 December 2020

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

1 reference

12 December 2020

A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells

1 reference

12 December 2020

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

1 reference

12 December 2020

HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma.

1 reference

12 December 2020

CD23 expression in mediastinal large B-cell lymphomas

1 reference

12 December 2020

Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy.

1 reference

12 December 2020

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

12 December 2020

Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival

1 reference

12 December 2020

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

1 reference

12 December 2020

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

12 December 2020

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

1 reference

12 December 2020

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

1 reference

12 December 2020

Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins

1 reference

12 December 2020

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

12 December 2020

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

12 December 2020

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

12 December 2020

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

1 reference

12 December 2020

Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.

1 reference

12 December 2020

Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells

1 reference

12 December 2020

Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma

1 reference

12 December 2020